Temozolomide in Preventing Brain Metastases in Small Cell Lung Cancer
Clinical trial NCT02605811 · UNKNOWN
Trial details
- NCT number
- NCT02605811
- Sponsor
- Guangzhou Medical University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2019-12-01
- Enrollment
- 426
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.